Abstract Objectives To assess the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1 RA) among patients with coexisting ischaemic heart disease (IHD) and type 2 diabetes (T2D) in primary care, in relation to European guidelines. Design Cross-sectional observational study. Setting 209 primary healthcare centres in Region Västra Götaland, Sweden (population 1.8 million in 2023).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Margareta
Contact Margareta, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack